Acquiring Company
Eli Lilly and Company
Acquired Company
AtaiBeckley
IndianapolisUnited StatesManufacturingBiotechnologyHealth CareMedicalPharmaceuticalBiotechnologyHealth CareTherapeuticsDescription
Eli Lilly and Company has proposed to acquire AtaiBeckley Inc. for $6.75 per share in cash, along with potential additional payments tied to specific milestones. A legal investigation is underway to assess the adequacy of the proposed sale price. Shareholders of AtaiBeckley are urged to evaluate their rights regarding the transaction.
Quick answer
Eli Lilly and Company is acquiring AtaiBeckley, announced August 28, 2026. Eli Lilly and Company is based in Indianapolis, Indiana, United States.
- How much did Eli Lilly and Company pay for AtaiBeckley?
- The deal value was not disclosed.
- What does Eli Lilly and Company do?
- Lilly is a medicine company turning science into healing to make life better for people around the world.
- Where are Eli Lilly and Company and AtaiBeckley based?
- Eli Lilly and Company is based in Indianapolis, Indiana, United States. AtaiBeckley is based in United States.
- Who are the decision-makers at Eli Lilly and Company?
- Fundz holds 5 contacts at Eli Lilly and Company. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Bristol-Myers acquires Medarex for cancer pipeline (August 2, 2026)
- Lifecore Biomedical Announces Merger with Lifecore Inc. (September 27, 2026)
- Eli Lilly to acquire Merida Biosciences for $2.875B, $2.9B (September 7, 2026)
- Jazz Pharmaceuticals acquires Actio Biosciences (August 10, 2026)
- Supernus to merge with Indivior Pharmaceuticals (August 3, 2026)
Who to call at Eli Lilly and Company, and when
When Eli Lilly and Company changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Eli Lilly and Company raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eli Lilly and Company, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eli Lilly and Company. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eli Lilly and Company makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired AtaiBeckley?
AtaiBeckley was acquired by Eli Lilly and Company, based in Indianapolis. The deal was reported on August 28, 2026. Lilly is a medicine company turning science into healing to make life better for people around the world. Eli Lilly and Company is publicly traded (LLY) and operates in Manufacturing.
When did Eli Lilly and Company acquire AtaiBeckley?
Eli Lilly and Company's acquisition of AtaiBeckley was reported on August 28, 2026. Eli Lilly and Company has proposed to acquire AtaiBeckley Inc. for $6.75 per share in cash, along with potential additional payments tied to specific milestones. A legal investigation is underway to assess the adequacy of the proposed sale price. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does AtaiBeckley do?
AtaiBeckley Inc. is a biotechnology company based in Delaware, primarily focused on the development of novel therapeutics for mental health disorders. It is privately held, operating in Biotechnology, and is based in United States.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.